Pancreas transplant alone

Current Opinion in Organ Transplantation

Volumn 20, Issue 1, 2015, Pages 115-120

  Niederhaus, Silke V ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

bionic pancreas; diabetes; immunotherapy; pancreas transplant

Indexed keywords

CARDIOVASCULAR RISK; DIABETES MELLITUS; GENE THERAPY; GRAFT REJECTION; HUMAN; IMMUNOTHERAPY; KIDNEY DISEASE; PANCREAS TRANSPLANTATION; PREVALENCE; RETRANSPLANTATION; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; ANIMAL; GRAFT SURVIVAL;

ANIMALS; DIABETES MELLITUS; GRAFT SURVIVAL; HUMANS; PANCREAS TRANSPLANTATION;

EID: 84921422950     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000157     Document Type: Review

References (32)

1. Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311:1778-1786.
2. O'Brien T. Gene therapy for type 1 diabetes moves a step closer to reality. Diabetes 2013; 62:1396-1397.
3. Gruessner RW, Gruessner AC. Pancreas transplant alone: a procedure coming of age. Diabetes Care 2013; 36:2440-2447.
4. Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol 2013; 9:555-562.
5. Kandaswamy R, Stock PG, Skeans MA, et al. OPTN/SRTR 2011 annual data report: pancreas. Am J Transplant 2012; 13 (Suppl 1):47-72.
6. Skyler JS, Sosenko JM. The evolution of type 1 diabetes. JAMA 2013; 309:2491-2492.
7. Nathan DM, Bayless M, Cleary P, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: advances and contributions. Diabetes 2013; 62:3976-3986.
8. Dong M, Parsaik AK, Kremers W, et al. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation. Am J Transplant 2013; 13:1019-1025.
9. Shah AP, Mangus RS, Powelson JA, et al. Impact of recipient age on whole organ pancreas transplantation. Clin Transplant 2013; 27:E49-E55.
10. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014; 371:313-325.
11. Hampton T. Fully automated artificial pancreas finally within reach. JAMA 2014; 311:2260-2261.
12. Herold KC, Gitelman SE, Ehlers MR, et al. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes 2013; 62:3766-3774.
13. Hagopian W, Ferry RJ Jr, Sherry N, et al. Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebocontrolled Protege trial. Diabetes 2013; 62:3901-3908.
14. Daifotis AG, Koenig S, Chatenoud L, Herold KC. Anti-CD3 clinical trials in type 1 diabetes mellitus. Clin Immunol 2013; 149:268-278.
15. Skyler JS. The compelling case for anti-CD3 in type 1 diabetes. Diabetes 2013; 62:3656-3657.
16. Callejas D, Mann CJ, Ayuso E, et al. Treatment of diabetes and long-Term survival after insulin and glucokinase gene therapy. Diabetes 2013; 62:1718-1729.
17. Maffi P, Balzano G, Ponzoni M, et al. Autologous pancreatic islet transplantation in human bone marrow. Diabetes 2013; 62:3523-3531.
18. Pileggi A, Ricordi C. A new home for pancreatic islet transplants: the bone marrow. Diabetes 2013; 62:3333-3335.
19. Pagliuca FW, Millman JR, Gurtler M, et al. Generation of functional human pancreatic b cells in vitro. Cell 2014; 159:428-439.
20. Hartono C, Kim J, McDermott J, et al. High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection. Transplantation 2013; 96:E43-E44.
21. Finger EB, Radosevich DM, Dunn TB, et al. A composite risk model for predicting technical failure in pancreas transplantation. Am J Transplant 2013; 13:1840-1849.
22. Scheffert JL, Taber DJ, Pilch NA, et al. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation 2014; 97:681-685.
23. Buron F, Thaunat O, Demuylder-Mischler S, et al. Pancreas retransplantation: a second chance for diabetic patients?. Transplantation 2013; 95:347-352.
24. Fridell JA, Stratta RJ. Program-specific reports for pancreas transplantation: comparing apples and oranges, apples after oranges and apples alone. Am J Transplant 2013; 13:251-252.
25. Kasiske BL, Gustafson S, Salkowski N, et al. Optimizing the program-specific reporting of pancreas transplant outcomes. Am J Transplant 2013; 13:337-347.
26. Nata N, Huang E, Kamgar M, et al. Kidney failure requiring kidney transplantation after pancreas transplant alone. Clin Transpl 2013; 45-52.
27. Kim SJ, Smail N, Paraskevas S, et al. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease. Transplantation 2014; 97:675-680.
28. van Dellen D, Worthington J, Mitu-Pretorian OM, et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant 2013; 28:1315-1322.
29. Mangus RS, Powelson J, Kinsella SB, et al. Pretransplant coronary artery disease associated with worse clinical outcomes in pancreas transplantation. Clin Transplant 2013; 27:E442-E447.
30. Perosa M, Noujaim H, Ianhez LE, et al. Experience with 53 portal-duodenal drained solitary pancreas transplants. Clin Transplant 2014; 28:198-204.
31. Rogers J, Farney AC, Orlando G, et al. Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Clin Transplant 2014; 28:16-26.
32. Barlow AD, Hosgood SA, Nicholson ML. Current state of pancreas preservation and implications for DCD pancreas transplantation. Transplantation 2013; 95:1419-1424.